arrow
A

Andrea Mastrangelo

university of bologna
H指数:13
被引数:532

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cerebrospinal fluid amyloid and neurodegeneration biomarkers in the diagnosis and prognosis of amyotrophic lateral sclerosis: a multicohort observational study

脑脊液淀粉样蛋白和神经退行性生物标志物在肌萎缩侧索硬化症的诊断和预后中的作用:一项多队列观察性研究

2026-10-200
OAAI
Changes in five cerebrospinal fluid and three plasma Alzheimer’s disease biomarkers across increasing brain amyloid-beta and tau pathology burden

五种脑脊液和三种血浆阿尔茨海默病生物标志物随大脑淀粉样蛋白β和tau病理负荷增加而发生的变化

2026-09-030
OAAI
Clinical correlates of a negative cerebrospinal fluid α-synuclein seed amplification assay result in Parkinson’s disease

帕金森病中脑脊液α-突触核蛋白种子扩增实验阴性结果的临床相关性

2026-04-140
OAAI
Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson’s disease

帕金森病中通过终点稀释种子扩增试验对脑脊液α-突触核蛋白种子的定量分析

2025-12-010
OAAI
Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participants

通过脑脊液终点稀释RT-QuIC对临床异质性参与者神经病理学尸检队列中的路易体病理性进行量化

2025-06-230
OAAI
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden

与Lewy体病分期和病理负担有关的脑脊液和脑组织中错误折叠 α-突触核蛋白的种子扩增测定的性能

2024-01-1922
OAAI
Amyloid-Beta Co-Pathology Is a Major Determinant of the Elevated Plasma GFAP Values in Amyotrophic Lateral Sclerosis

Β 淀粉样蛋白共病理是肌萎缩性侧索硬化症患者血浆GFAP值升高的主要决定因素

2023-09-123
OAAI